定量核磁共振氢谱法测定枸橼酸托法替布片的有效含量

建立了枸橼酸托法替布片中有效含量的定量核磁共振氢谱测定方法。以托法替布化学位移δ 7.13为定量峰,3,5-二甲基吡唑化学位移δ 5.73为内标峰,氘代二甲亚砜（DMSO-D6）为溶剂,使用核磁共振谱仪采集混合物的氢谱,对枸橼酸托法替布片中的有效成分进行定量测定。该方法专一性强,在0.793～7.925 mg/mL范围内呈现良好的线性关系（r2=0.998 4）。精密度、重复性和稳定性的相对标准偏差（RSD）分别为0.82%、1.7%和0.67%。该方法测得的枸橼酸托法替布片中托法替布的质量分数为2.25%,其结果与高效液相色谱法基本一致。定量核磁共振氢谱法具有操作方便简单,可同时进行定性与定量,检测时间短,无需对照品等优势,可用于枸橼酸托法替布片有效含量的测定。     

核磁共振定量法测定利培酮含量

采用氢核磁共振定量法和氟核磁共振定量法测定利培酮含量。氢核磁共振定量法以利培酮δ7.29~7.35处质子峰为定量峰,马来酸δ6.02处为内标峰,在恒温300 K,采样时间4.0 s,弛豫延迟时间15 s,扫描次数为32次条件下采集氢谱。氟核磁共振定量法以4-溴-2-氟-乙酰苯胺为内标,在恒温300 K,谱宽12 500.0 Hz,中心频率-43 662.7 Hz下采集氟谱。测试结果显示,利培酮氢核磁共振定量法和氟核磁共振定量法的含量测定结果基本与质量平衡法的结果一致。因此,核磁共振法可用于利培酮绝对含量的测定,具有快速、简单、准确的优势。     

核磁共振波谱法测定依非韦伦含量

分别采用氢核磁共振定量法和氟核磁共振定量法测定依非韦伦含量。氢核磁共振定量法以依非韦伦δ1.58～1.65处质子峰为定量峰,马来酸δ6.22处为内标峰。氟核磁共振定量法以δ-80.58处作为定量峰,4-溴-2-氟-乙酰苯胺δ-121.70作为内标峰。通过比较依非韦伦的定量峰与内标物质内标峰峰面积,计算依非韦伦的含量。测试结果显示,氢核磁共振定量法和氟核磁共振定量法的含量测定结果基本一致。因此,核磁共振法可用于依非韦伦绝对含量的测定,具有快速、准确的优势。     

核磁共振法定性和定量分析磷酸奥司他韦胶囊

采用核磁共振法(NMR)对磷酸奥司他韦胶囊进行定性和定量。选择马来酸化学位移δ:6.20～6.40处质子峰为内标峰,磷酸奥司他韦化学位移δ:6.76～6.88处为定量峰,采集混合物的定量核磁共振氢谱(¹H qNMR),对内标峰和定量峰积分后计算含量。结果显示,磷酸奥司他韦胶囊成分的化学结构与磷酸奥司他韦一致。磷酸奥司他韦线性范围是6.64～16.65 mg·mL^-1,回收率达到99.62%,精密度和稳定性良好,方法学专属性高。¹H qNMR法与HPLC法的测定结果基本一致。因此,建立的¹H qNMR法可用于磷酸奥司他韦胶囊定性和定量研究,提供了一种质量控制方法。     

一种新西地那非类似物的结构确证

采用核磁共振氢谱(1H NMR)、核磁共振碳谱(13C NMR)、梯度场氢氢相关化学位移相关谱(1H-1H COSY)、梯度场质子检测异核单量子化学位移相关谱(HSQC)、梯度场质子检测异核多重键化学位移相关谱(HMBC)等多种NMR分析方法,结合红外光谱分析和元素分析,确证了5-[2-丙氧基-5-(3,5-二甲基哌嗪-1-基磺基)苯基]-1-甲基-3-正丙基-1,6-二氢-7H-吡唑并[4,3-d]嘧啶-7-酮的分子结构,为鉴定西地那非类似物提供了重要依据。     

^(1)H和^(19)F核磁共振定量法测定诺氟沙星标准品的绝对含量EI北大核心CSCD

采用^(1)H和^(19)F核磁共振定量法测定诺氟沙星标准品的绝对含量。^(1)H核磁共振定量法以DMSO-d6为溶剂,诺氟沙星峰(δ7.9)为定量峰,马来酸峰(δ6.3)为内标峰。在脉冲程序zg30,采样时间4.09 s,延迟时间20 s,扫描次数为16的条件下采集氢谱。^(19)F核磁共振定量法以利培酮为内标物,诺氟沙星峰(δ-121.3)为定量峰,利培酮峰(δ-109.9)为内标峰。在脉冲程序zgfhigqn.2,延迟时间7 s,扫描次数为16的条件下采集氟谱。^(1)H和^(19)F核磁共振定量法测定结果接近,且与质量平衡法测定结果一致。核磁共振定量法可用来测定诺氟沙星绝对含量,快速、简单高效、且不需要对照品。     

核磁共振波谱法鉴定伪展着剂

主要应用核磁共振波谱法（NMR）（氢谱,碳谱）,定性、定量地鉴定伪展着剂为百草敌水剂,使用标准品及重量差法进行了确证,结果表明,NMR法能对组成简单的医药、农药等进行定性、定量分析。     

核磁共振氢谱内标法测定茚地普隆的含量

建立了测定无对照品的新型非苯二氮唑类镇静催眠药茚地普隆含量的快速、专属、简单的核磁共振氢谱内标法。用Varian Mercury Plus400MHz核磁共振谱仪,在25℃、以氘代氯仿为溶剂、3,4-二硝基甲苯为内标、观察频率400.121MHz、谱宽6410Hz、90°脉冲宽度6.45μs、采集时间4s和延迟时间15s的条件下采集试样的氢谱。以化学位移分别在δ8.72和δ8.72处的茚地普隆和3,4-二硝基甲苯的单峰作为定量峰,其峰面积比(As/Ar,y)与其质量比(ms/mr,x)的线性回归方程为y=6.1458x 0.0055,相关系数为r=0.99996,含量测定重复性实验的RSD为0.29%(n=6)。分析结果表明,在没有对照品的情况下,核磁共振氢谱内标法,可用于茚地普隆的含量测定和质量控制。     

苏丹红Ⅰ、Ⅱ标准物质纯度的核磁共振法测定

采用核磁共振氢谱法(1H NMR)测定了苏丹红Ⅰ及苏丹红Ⅱ标准物质的纯度。分别以国家一级标准物质苯甲酸(GBW 13233)和国家二级标准物质尼泊金乙酯(GBW(E)100064)为内标,以氘代氯仿为溶剂,使用B ruker AVANCE DRX-500 NMR仪进行检测。实验优化了弛豫时间、扫描次数等定量参数,对定量峰的选择与积分进行了讨论。优化后的弛豫时间为30 s,扫描次数为32次;苏丹红Ⅰ、Ⅱ的纯度分别为96.1%、87.5%,其测量相对标准偏差分别为0.4%、0.6%。     

肌酐纯度标准物质的定值方法及其不确定度评定研究

通过定性及定量分析,研究了肌酐纯度标准物质的定值方法,并进行了定值分析的不确定度评定。首先使用三重四极杆质谱仪及核磁共振谱仪(氢谱)对肌酐样品进行定性分析,然后采用质量平衡法(包括液相色谱法、水分、灰分、挥发性物质和无机元素分析)与定量核磁共振法共同对肌酐纯度标准物质进行准确定值,最后对定值结果进行不确定度评定。肌酐的定值结果为99.7%,扩展不确定度为0.4%。该研究对于实际检测中肌酐的准确测定及临床上相关疾病的正确诊断治疗具有重要意义,且经过定值的肌酐纯品还可做定量核磁共振法的定量内标使用。定量分析后的肌酐经过均匀性检验和稳定性考察后可申报为国家标准物质。     

Correlating light and thermal stability of silver carboxylate complexes by infrared and 13C NMR spectroscopy

Bond nature of carboxylic groups can play an important role in Ag(I)-carboxylate compounds because light and thermal stability are important requirements for future applications such as antibacterial additives. A linear correlation between bond character and light stability of silver carboxylate complexes has been predicted by a direct relationship of infrared and ¹³C NMR spectroscopic data. This correlation is in agreement with the thermogravimetric analysis and provides a new approach to explore the interaction and the physical properties of metal-carboxylate bonds.     

Improving on equilibrium isotropic nuclear shielding constants

Isotropic nuclear shielding constants at the equilibrium molecular structure σ_eq and zero‐point vibrational corrections (ZPVCs) to σ_eq are evaluated using the B3LYP/aug‐cc‐pVTZ level of theory, as well as the KT2/aug‐cc‐pVTZ level of theory. Various scaling factors and systematic corrections are obtained by linear regression to experimental shielding constants. Comparisons of the scaled and systematically corrected equilibrium and vibrationally averaged shielding constants reveal that, at the 99% confidence level, the ZPVCs via second‐order perturbation theory do not improve the agreement of B3LYP/aug‐cc‐pVTZ and KT2/aug‐cc‐pVTZ calculated shielding constants with experiment. This holds true when the same analysis is applied to CCSD(T)/aug‐cc‐pCV[TQ]Z calculated σ_eq of Teale et al. [Journal of Chemical Physics 2013, 138, 024111]. In addition, at the 99% confidence level, B3LYP/aug‐cc‐pVTZ and KT2/aug‐cc‐pVTZ scaled and systematically corrected shielding constants are found to be statistically no different from CCSD(T)/aug‐cc‐pCV[TQ]Z calculated σ_eq. The use of scaling factors and systematic corrections could thus provide a cheaper but yet reasonably accurate alternative for the study of nuclear shielding constants of larger systems.     

Early Days of Two-Dimensional Ion Cyclotron Resonance

This contribution is an attempt to evoke the favorable atmosphere that prevailed in Lausanne around 1986 and provided the backdrop of our invention of two-dimensional ion cyclotron resonance mass spectroscopy (2D ICR-MS). To avoid a self-centered histoire d’ancien combattant, we shall try to emphasize the context: the contributions of key players within our nascent research group at UNIL and the established group of Tino Gäumann at EPFL, the role of external speakers, and the open atmosphere that was not yet polluted by bibliometrics, obsessive concern with impact factors, and top–down management of research. We shall also explain why the idea of 2D ICR-MS has been ignored for many years and still has a limited impact: different scientific cultures in the ICR and NMR communities, different concerns with fundamental vs. applied research, different status of theory and numerical simulations, different levels of commitment of instrument manufacturers, not to mention many theoretical problems that appear to be at least as challenging in ICR as in NMR.